Jinyu Bio-Technology Co., Ltd.

Jinyu Bio-Technology Co., Ltd. saw a notable stock decline today, contrasting with the broader market's performance. Despite recent setbacks, the company has achieved a strong annual return. However, it faces challenges in management efficiency and has reported negative results for four consecutive quarters, raising concerns about its valuation.

Jinyu Bio-Technology Co., Ltd. saw a notable rise in stock performance on March 18, 2026, reaching an intraday high. The company has outperformed the China Shanghai Composite over the past week and year, but faces challenges in management efficiency and long-term growth, with declining net sales and operating profit.

Jinyu Bio-Technology Co., Ltd. saw a significant stock decline today, contrasting with the broader market. Despite a strong annual return, the company has struggled recently with negative results and declining sales. Its market capitalization is CNY 17,377 million, indicating a large-cap status in the Pharmaceuticals & Biotechnology sector.